Announcements Trials
Browse Landscape

Phase

Phase NA 2

Status

Completed 2Unknown 1Recruiting 1Active not recruiting 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 3Tumor-Agnostic 2Gastrointestinal 2CNS 2Lymphoid 1Genitourinary 1

Conditions

Pancreatic Neoplasms 2Hypoxia 1

Interventions

Fluorouracil 616Oxaliplatin 579Gemcitabine 492Capecitabine 445Leucovorin 427Irinotecan 390Bevacizumab 330Cisplatin 320Radiotherapy 245Cetuximab 215Sorafenib 167pembrolizumab 152Docetaxel 150Paclitaxel 140Nivolumab 128Albumin-Bound Paclitaxel 108130-nm albumin-bound paclitaxel 108Folfox protocol 101Panitumumab 95Erlotinib Hydrochloride 95Surgical Procedures, Operative 86regorafenib 84S 1 (combination) 81Drug Therapy 80Radiation 69Carboplatin 65Neoadjuvant Therapy 64Colonoscopy 64Radiosurgery 63Surveys and Questionnaires 60

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Completed × gadobutrol × Gastrointestinal × Clear all
NCT01989000 2018-06-27

MIPA

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase NA Completed
47 enrolled
Gastrointestinal

Hypoxia, Pancreatic Neoplasms

NCT01995240 2017-03-20

REMP

Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)

Phase NA Completed
23 enrolled
Gastrointestinal

Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡